Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.

Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB.

J Invasive Cardiol. 2003 Jan;15(1):18-22.

PMID:
12499523
[PubMed - indexed for MEDLINE]
2.

Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.

Chong E, Poh KK, Liang S, Tan HC.

Ann Acad Med Singapore. 2010 May;39(5):374-80.

PMID:
20535427
[PubMed - indexed for MEDLINE]
Free Article
3.

Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL.

J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5.

PMID:
15519007
[PubMed - indexed for MEDLINE]
Free Article
4.

Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.

Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2008 Jun 1;101(11):1544-9. doi: 10.1016/j.amjcard.2008.02.035. Epub 2008 Apr 18.

PMID:
18489931
[PubMed - indexed for MEDLINE]
5.

Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.

Wickenbrock I, Perings C, Maagh P, Quack I, van Bracht M, Prull MW, Plehn G, Trappe HJ, Meissner A.

Clin Res Cardiol. 2009 Dec;98(12):765-72. doi: 10.1007/s00392-009-0058-5. Epub 2009 Oct 23.

PMID:
19851800
[PubMed - indexed for MEDLINE]
6.

Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.

Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD.

Am J Cardiol. 2004 Aug 1;94(3):300-5.

PMID:
15276092
[PubMed - indexed for MEDLINE]
7.

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R.

Am J Cardiol. 2005 Jan 1;95(1):13-9.

PMID:
15619387
[PubMed - indexed for MEDLINE]
8.

Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, Stabryła-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.

Kardiol Pol. 2007 Jun;65(6):635-43; discussion 644.

PMID:
17629825
[PubMed - indexed for MEDLINE]
Free Article
9.

Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions.

Aguiar-Souto P, Ferrante G, Del Furia F, Barlis P, Khurana R, Di Mario C.

Int J Cardiol. 2010 Feb 18;139(1):68-74. doi: 10.1016/j.ijcard.2008.10.006. Epub 2008 Dec 3.

PMID:
19056138
[PubMed - indexed for MEDLINE]
10.

Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.

Senoo T, Motohiro M, Kamihata H, Yamamoto S, Isono T, Manabe K, Sakuma T, Yoshida S, Sutani Y, Iwasaka T.

Am J Cardiol. 2010 Mar 1;105(5):624-8. doi: 10.1016/j.amjcard.2009.10.044.

PMID:
20185007
[PubMed - indexed for MEDLINE]
11.
12.

Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.

Chen SL, Zhang J, Yei F, Zhu Z, Liu Z, Lin S, Chu J, Yan J, Zhang R, Kwan TW.

Int J Cardiol. 2008 Jun 6;126(3):407-13. Epub 2007 Jul 24.

PMID:
17651830
[PubMed - indexed for MEDLINE]
13.

Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.

Jabara R, Gadesam RR, Pendyala LK, Knopf WD, Chronos N, Chen JP, Viel K, King SB 3rd, Manoukian SV.

Am J Cardiol. 2009 Jun 15;103(12):1657-62. doi: 10.1016/j.amjcard.2009.02.039. Epub 2009 Apr 16.

PMID:
19539072
[PubMed - indexed for MEDLINE]
14.

Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.

Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD.

Nephrology (Carlton). 2010 Mar;15(2):165-70. doi: 10.1111/j.1440-1797.2009.01204.x.

PMID:
20470274
[PubMed - indexed for MEDLINE]
15.

Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.

Hernández F, Mora L, García-Tejada J, Velázquez M, Gómez-Blázquez I, Bastante T, Albarrán A, Andreu J, Tascón J.

Rev Esp Cardiol. 2009 Dec;62(12):1373-80.

PMID:
20038403
[PubMed - indexed for MEDLINE]
Free Article
16.

A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.

Harjai KJ, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, Boura J, Aboufares A, Sporn D, Stapleton D.

Am J Cardiol. 2008 Mar 15;101(6):812-9. doi: 10.1016/j.amjcard.2007.10.051. Epub 2008 Jan 14.

PMID:
18328846
[PubMed - indexed for MEDLINE]
17.

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

Patti G, Nusca A, Chello M, Pasceri V, D'Ambrosio A, Vetrovec GW, Di Sciascio G.

Am J Cardiol. 2008 Feb 1;101(3):279-85. doi: 10.1016/j.amjcard.2007.08.030. Epub 2007 Dec 21.

PMID:
18237585
[PubMed - indexed for MEDLINE]
18.

Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.

Uddin MA, Rabbani MA, Jafary FH, Bhatti MA, Islam M.

J Coll Physicians Surg Pak. 2005 Dec;15(12):791-4.

PMID:
16398973
[PubMed - indexed for MEDLINE]
19.

Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.

Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL.

Ann Intern Med. 2009 Feb 3;150(3):170-7.

PMID:
19189906
[PubMed - indexed for MEDLINE]
20.

Risk score for contrast induced nephropathy following percutaneous coronary intervention.

Ghani AA, Tohamy KY.

Saudi J Kidney Dis Transpl. 2009 Mar;20(2):240-5.

PMID:
19237811
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk